VWA5B1
gene geneOn this page
Also known as FLJ32784
Summary
VWA5B1 (von Willebrand factor A domain containing 5B1, HGNC:26538) is a protein-coding gene on chromosome 1p36.12, encoding von Willebrand factor A domain-containing protein 5B1 (Q5TIE3).
Predicted to be located in extracellular region.
Source: NCBI Gene 127731 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 269 total
- MANE Select transcript:
NM_001039500
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26538 |
| Approved symbol | VWA5B1 |
| Name | von Willebrand factor A domain containing 5B1 |
| Location | 1p36.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32784 |
| Ensembl gene | ENSG00000158816 |
| Ensembl biotype | protein_coding |
| Entrez | 127731 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000289815, ENST00000375079, ENST00000467486, ENST00000473325, ENST00000485375, ENST00000525343, ENST00000530722, ENST00000534075, ENST00000893215, ENST00000919186
RefSeq mRNA: 2 — MANE Select: NM_001039500
NM_001039500, NM_001377531
Canonical transcript exons
ENST00000289815 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001465717 | 20353757 | 20359518 |
| ENSE00003459903 | 20343079 | 20343393 |
| ENSE00003468152 | 20342432 | 20342609 |
| ENSE00003469044 | 20312836 | 20312988 |
| ENSE00003481661 | 20330869 | 20330983 |
| ENSE00003490240 | 20314322 | 20314592 |
| ENSE00003526661 | 20323356 | 20323532 |
| ENSE00003535492 | 20317530 | 20317675 |
| ENSE00003538106 | 20336303 | 20336486 |
| ENSE00003540697 | 20318590 | 20318721 |
| ENSE00003544618 | 20350156 | 20350230 |
| ENSE00003555040 | 20350857 | 20350926 |
| ENSE00003556325 | 20345456 | 20345593 |
| ENSE00003578463 | 20310576 | 20310740 |
| ENSE00003599261 | 20332766 | 20332951 |
| ENSE00003619438 | 20337646 | 20337836 |
| ENSE00003623242 | 20348245 | 20348358 |
| ENSE00003628100 | 20327890 | 20328000 |
| ENSE00003653609 | 20319382 | 20319506 |
| ENSE00003670631 | 20330180 | 20330382 |
| ENSE00003693096 | 20352055 | 20352172 |
| ENSE00003921465 | 20290875 | 20291088 |
Expression profiles
Bgee: expression breadth broad, 90 present calls, max score 72.39.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0550 / max 12.9796, expressed in 25 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1118 | 0.0550 | 25 |
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 72.39 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.05 | gold quality |
| left testis | UBERON:0004533 | 71.36 | gold quality |
| right testis | UBERON:0004534 | 70.33 | gold quality |
| testis | UBERON:0000473 | 68.96 | gold quality |
| right uterine tube | UBERON:0001302 | 68.36 | gold quality |
| ventricular zone | UBERON:0003053 | 64.32 | gold quality |
| hypothalamus | UBERON:0001898 | 63.55 | gold quality |
| metanephros cortex | UBERON:0010533 | 61.47 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 60.40 | gold quality |
| ganglionic eminence | UBERON:0004023 | 59.50 | gold quality |
| metanephros | UBERON:0000081 | 55.21 | gold quality |
| kidney | UBERON:0002113 | 54.51 | gold quality |
| gall bladder | UBERON:0002110 | 53.51 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 53.10 | gold quality |
| cortex of kidney | UBERON:0001225 | 52.90 | gold quality |
| urinary bladder | UBERON:0001255 | 50.25 | gold quality |
| gingival epithelium | UBERON:0001949 | 50.10 | gold quality |
| buccal mucosa cell | CL:0002336 | 49.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.46 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 49.43 | gold quality |
| tonsil | UBERON:0002372 | 48.41 | silver quality |
| amygdala | UBERON:0001876 | 47.89 | gold quality |
| caudate nucleus | UBERON:0001873 | 47.80 | gold quality |
| gingiva | UBERON:0001828 | 46.96 | gold quality |
| fallopian tube | UBERON:0003889 | 46.40 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 46.22 | gold quality |
| upper leg skin | UBERON:0004262 | 46.12 | silver quality |
| forebrain | UBERON:0001890 | 45.81 | gold quality |
| Ammon’s horn | UBERON:0001954 | 45.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 39.42 |
| E-ANND-3 | yes | 5.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting VWA5B1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
| HSA-MIR-3176 | 99.25 | 64.35 | 954 |
| HSA-MIR-3922-3P | 99.25 | 64.96 | 1136 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-628-3P | 99.04 | 68.37 | 814 |
| HSA-MIR-7153-3P | 99.00 | 65.35 | 608 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-455-5P | 98.74 | 67.31 | 795 |
| HSA-MIR-5011-3P | 98.63 | 64.81 | 638 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-5008-5P | 98.42 | 65.87 | 1019 |
| HSA-MIR-6842-3P | 98.07 | 66.33 | 1325 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-6736-3P | 96.98 | 65.22 | 1342 |
| HSA-MIR-212-5P | 96.83 | 67.43 | 950 |
| HSA-MIR-550B-2-5P | 96.56 | 64.61 | 646 |
| HSA-MIR-4654 | 95.86 | 65.72 | 751 |
| HSA-MIR-4259 | 95.68 | 65.25 | 582 |
| HSA-MIR-4769-5P | 95.37 | 66.09 | 570 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vwa5b1 | ENSDARG00000059705 |
| mus_musculus | Vwa5b1 | ENSMUSG00000028753 |
| rattus_norvegicus | Vwa5b1 | ENSRNOG00000016553 |
Paralogs (11): ITIH4 (ENSG00000055955), ITIH1 (ENSG00000055957), ITIH6 (ENSG00000102313), PARP4 (ENSG00000102699), VWA5A (ENSG00000110002), ITIH5 (ENSG00000123243), VWA5B2 (ENSG00000145198), ITIH2 (ENSG00000151655), ITIH3 (ENSG00000162267), VWA3B (ENSG00000168658), VWA3A (ENSG00000175267)
Protein
Protein identifiers
von Willebrand factor A domain-containing protein 5B1 — Q5TIE3 (reviewed: Q5TIE3)
All UniProt accessions (6): E9PMB3, E9PNX8, E9PP07, E9PQ62, Q5TIE3, H0YED8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TIE3-1 | 1 | yes |
| Q5TIE3-2 | 2 | |
| Q5TIE3-3 | 3 | |
| Q5TIE3-4 | 4 | |
| Q5TIE3-5 | 5 |
RefSeq proteins (2): NP_001034589, NP_001364460 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002035 | VWF_A | Domain |
| IPR013694 | VIT | Domain |
| IPR036465 | vWFA_dom_sf | Homologous_superfamily |
| IPR052627 | VWA_domain-containing | Family |
Pfam: PF13757, PF13768
UniProt features (30 total): splice variant 8, sequence variant 4, region of interest 4, compositionally biased region 3, glycosylation site 3, sequence conflict 3, domain 2, signal peptide 1, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TIE3-F1 | 66.50 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 881
Glycosylation sites (3): 140, 650, 1017
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 19 (showing top):
HAND1E47_01, TAL1BETAE47_01, chr1p36, NABA_ECM_GLYCOPROTEINS, MIR3922_3P, MIR3176, DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS, DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP, GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN, OLF1_01, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN, NABA_CORE_MATRISOME, NABA_MATRISOME
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
564 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VWA5B1 | KIAA2012 | Q0VF49 | 666 |
| VWA5B1 | VSTM5 | A8MXK1 | 542 |
| VWA5B1 | XKR5 | Q6UX68 | 507 |
| VWA5B1 | TATDN2 | Q93075 | 483 |
| VWA5B1 | ARL5C | A6NH57 | 482 |
| VWA5B1 | DUSP21 | Q9H596 | 433 |
| VWA5B1 | TMEM87B | Q96K49 | 379 |
| VWA5B1 | ZPLD1 | Q8TCW7 | 366 |
| VWA5B1 | MFAP1 | P55081 | 324 |
| VWA5B1 | CLBA1 | Q96F83 | 323 |
| VWA5B1 | SKIC3 | Q6PGP7 | 311 |
| VWA5B1 | COL26A1 | Q96A83 | 303 |
| VWA5B1 | LRWD1 | Q9UFC0 | 302 |
| VWA5B1 | TICRR | Q7Z2Z1 | 299 |
| VWA5B1 | HIVEP3 | Q5T1R4 | 295 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VWA5B1 | H2BC21 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): VWA5B1 (Proximity Label-MS)
ESM2 similar proteins: A0A140LI67, A2AKB4, A6QLD5, A9Z1V5, C0HAC0, D4A7V9, O43187, O70173, O88866, P97573, Q08DV9, Q0P5I2, Q1L981, Q2YDQ5, Q3TYG6, Q3U3D7, Q4QQS0, Q5F479, Q5JV73, Q5R810, Q5SUS0, Q5SY16, Q5TIE3, Q5XX13, Q68DX3, Q6DIL6, Q6GQ34, Q6IRN0, Q6IRU7, Q6P1H6, Q6P4K6, Q6P4T1, Q80TI1, Q8BLA1, Q8BLQ0, Q8BW88, Q8C008, Q8CFA1, Q8QHJ9, Q8TC57
Diamond homologs: A9Z1V5, C7G046, O00534, Q3UR50, Q54CQ8, Q54DU5, Q54DV3, Q54MG1, Q54MG4, Q55G98, Q5TIE3, Q75WE7, Q8N398, A0A1S3C4H6, B9FXV5, G5CEW6, O43432, P41110, Q03387, Q04637, Q41583, Q6K641, Q6NZJ6, Q76E23, Q80XI3, Q84PB3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
269 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 247 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4397 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:20310739:GG:G | donor_gain | 1.0000 |
| 1:20310740:GG:G | donor_gain | 1.0000 |
| 1:20310740:GGT:G | donor_loss | 1.0000 |
| 1:20310741:GTAAG:G | donor_loss | 1.0000 |
| 1:20310742:T:A | donor_loss | 1.0000 |
| 1:20312987:AGG:A | donor_loss | 1.0000 |
| 1:20312988:GGTAA:G | donor_loss | 1.0000 |
| 1:20312989:GT:G | donor_loss | 1.0000 |
| 1:20312990:T:G | donor_loss | 1.0000 |
| 1:20314370:C:A | acceptor_gain | 1.0000 |
| 1:20318580:T:G | acceptor_gain | 1.0000 |
| 1:20318719:GCG:G | donor_gain | 1.0000 |
| 1:20318722:G:GG | donor_gain | 1.0000 |
| 1:20330341:G:T | donor_gain | 1.0000 |
| 1:20330342:A:T | donor_gain | 1.0000 |
| 1:20332947:GATCT:G | donor_gain | 1.0000 |
| 1:20332952:G:GG | donor_gain | 1.0000 |
| 1:20336300:CAG:C | acceptor_loss | 1.0000 |
| 1:20336301:A:AC | acceptor_loss | 1.0000 |
| 1:20336301:AG:A | acceptor_gain | 1.0000 |
| 1:20336302:GG:G | acceptor_gain | 1.0000 |
| 1:20336302:GGACA:G | acceptor_gain | 1.0000 |
| 1:20336482:GCACG:G | donor_gain | 1.0000 |
| 1:20343078:GAGCC:G | acceptor_gain | 1.0000 |
| 1:20343389:GCAGG:G | donor_gain | 1.0000 |
| 1:20343392:GG:G | donor_gain | 1.0000 |
| 1:20343393:GG:G | donor_gain | 1.0000 |
| 1:20345452:A:AG | acceptor_gain | 1.0000 |
| 1:20345452:ACAG:A | acceptor_gain | 1.0000 |
| 1:20345452:ACAGG:A | acceptor_gain | 1.0000 |
AlphaMissense
7951 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:20318598:A:C | S240R | 0.998 |
| 1:20318600:T:A | S240R | 0.998 |
| 1:20318600:T:G | S240R | 0.998 |
| 1:20332823:T:A | W544R | 0.996 |
| 1:20332823:T:C | W544R | 0.996 |
| 1:20312886:G:C | A64P | 0.994 |
| 1:20345494:A:C | S889R | 0.994 |
| 1:20345496:C:A | S889R | 0.994 |
| 1:20345496:C:G | S889R | 0.994 |
| 1:20354033:T:A | W1145R | 0.993 |
| 1:20354033:T:C | W1145R | 0.993 |
| 1:20345515:A:C | S896R | 0.992 |
| 1:20345517:C:A | S896R | 0.992 |
| 1:20345517:C:G | S896R | 0.992 |
| 1:20354093:T:A | W1165R | 0.992 |
| 1:20354093:T:C | W1165R | 0.992 |
| 1:20310705:T:C | L35P | 0.991 |
| 1:20317646:T:C | L227P | 0.990 |
| 1:20312881:T:C | F62S | 0.989 |
| 1:20354114:G:C | A1172P | 0.989 |
| 1:20318617:G:C | R246P | 0.988 |
| 1:20312880:T:C | F62L | 0.986 |
| 1:20312882:T:A | F62L | 0.986 |
| 1:20312882:T:G | F62L | 0.986 |
| 1:20354035:G:C | W1145C | 0.986 |
| 1:20354035:G:T | W1145C | 0.986 |
| 1:20310612:T:C | L4S | 0.985 |
| 1:20343208:T:A | V814D | 0.985 |
| 1:20354095:G:C | W1165C | 0.985 |
| 1:20354095:G:T | W1165C | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000027948 (1:20344085 C>G,T), RS1000084957 (1:20313953 A>G), RS1000119951 (1:20337896 T>C), RS1000173985 (1:20350259 A>C,G), RS1000203878 (1:20311823 C>A,T), RS1000231277 (1:20307189 C>T), RS1000257968 (1:20350102 G>A), RS1000262344 (1:20306972 T>C), RS1000375733 (1:20355546 C>A,G), RS1000385097 (1:20316517 A>G), RS1000514884 (1:20326778 A>G), RS1000525692 (1:20301918 G>A), RS1000560273 (1:20331159 T>G), RS1000560530 (1:20305851 G>A,T), RS1000588732 (1:20349673 T>TGCC)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004685_1 | Psychosis proneness (perceptual aberration scale) | 4.000000e-06 |
| GCST007478_1 | Non-word reading | 6.000000e-06 |
| GCST010002_378 | Refractive error | 1.000000e-09 |
| GCST010118_1 | Type 2 diabetes | 4.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008337 | psychosis predisposition measurement |
| EFO:0005299 | non-word reading |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Aldehydes | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Vanadium | increases abundance, increases methylation | 1 |
| Metals, Heavy | increases abundance, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.